Comparison between Delhivery IPO and Supriya Lifescience IPO.
Delhivery IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Delhivery IPO is up to ₹5,235.00 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Delhivery IPO is ₹487.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
| Delhivery IPO | Supriya Lifescience IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹2 per share |
| Issue Price (Lower) | ₹462.00 per share | ₹265.00 per share |
| Issue Price (Upper) | ₹487.00 per share | ₹274.00 per share |
| Issue Price (Final) | ₹487.00 per share | ₹274.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹25.00 per share | |
| Market Lot Size | 30 shares | 54 shares |
| Fresh Issue Size | 8,21,37,328 shares | 72,99,270 shares |
| Fresh Issue Size (Amount) | up to ₹4,000.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 2,53,59,897 shares | 1,82,48,175 shares |
| OFS Issue Size (Amount) | up to ₹1,235.00 Cr | up to ₹500.00 Cr |
| Issue Size Total | 10,74,97,225 shares | 2,55,47,445 shares |
| Issue Size Total (Amount) | up to ₹5,235.00 Cr | up to ₹700.00 Cr |
Delhivery IPO opens on May 11, 2022, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Delhivery IPO and Supriya Lifescience IPO is May 13, 2022, and Dec 20, 2021, respectively.
| Delhivery IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | May 10, 2022 | Dec 15, 2021 |
| Issue Open | May 11, 2022 | Dec 16, 2021 |
| Issue Close | May 13, 2022 | Dec 20, 2021 |
| Basis Of Allotment (Tentative) | May 19, 2022 | Dec 23, 2021 |
| Initiation of Refunds (Tentative) | May 20, 2022 | Dec 24, 2021 |
| Credit of Share (Tentative) | May 23, 2022 | Dec 27, 2021 |
| Listing date (Tentative) | May 24, 2022 | Dec 28, 2021 |
| Anchor Lockin End date 1 | Jun 18, 2022 | Jan 22, 2022 |
| Anchor Lockin End date 2 | Aug 17, 2022 | Mar 23, 2022 |
Delhivery IPO P/E ratio is -67.3, as compared to Supriya Lifescience IPO P/E ratio of .
| Delhivery IPO | Supriya Lifescience IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.98 | |||||
| Promoter Shareholding (Post-Issue) | 68.24 | |||||
| P/E Ratio | -67.3 | |||||
| Market Cap | ₹35283.22 Cr. | ₹700.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ₹-8.05 | |||||
| RoNW | -14.66 |
In the Delhivery IPO Retail Individual Investors (RII) are offered 1,07,08,418 shares while in Supriya Lifescience IPO retail investors are offered 1,07,08,418 shares. Qualified Institutional Buyers (QIB) are offered 3,21,25,282 shares in Delhivery IPO and 76,64,234 shares in Supriya Lifescience IPO.
| Delhivery IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,81,87,860 shares | 1,14,96,351 shares |
| Market Maker Reservation | ||
| QIB | 3,21,25,282 shares | 76,64,234 shares |
| NII | 1,60,62,628 shares | 38,32,116 shares |
| RII | 1,07,08,418 shares | 25,54,744 shares |
| Employee | 4,32,900 shares | |
| Others | ||
| Total | 10,75,17,088 shares | 2,55,47,445 shares |
Delhivery IPO subscribed 1.63x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
| Delhivery IPO | Supriya Lifescience IPO | |
|---|---|---|
| QIB (times) | 2.66x | 31.83x |
| NII (times) | 0.30x | 161.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.57x | 56.01x |
| Employee (times) | 0.27x | |
| Other (times) | 0.00x | |
| Total (times) | 1.63x | 71.51x |
